Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism (SQUED™)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03222375
Recruitment Status : Recruiting
First Posted : July 19, 2017
Last Update Posted : November 28, 2017
Sponsor:
Collaborators:
Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS
Institute of Medical Synergetics, Department of Cognitive Neurology WOMS
Laboratory of Neurocomputational Active Media WOMS
SQUED, Inc., USA
Center of Synergetics, Universität Stuttgart, Germany
Ivan Franko National University of Lviv, Ukraine
Danylo Halytsky Lviv National Medical University
World Organization of Medical Synergetics
World Autism Center, American Federation of Medical Synergetics
Information provided by (Responsible Party):
American Federation of Medical Synergetics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2022
Estimated Study Completion Date : December 2027